<code id='8D2ED61F49'></code><style id='8D2ED61F49'></style>
    • <acronym id='8D2ED61F49'></acronym>
      <center id='8D2ED61F49'><center id='8D2ED61F49'><tfoot id='8D2ED61F49'></tfoot></center><abbr id='8D2ED61F49'><dir id='8D2ED61F49'><tfoot id='8D2ED61F49'></tfoot><noframes id='8D2ED61F49'>

    • <optgroup id='8D2ED61F49'><strike id='8D2ED61F49'><sup id='8D2ED61F49'></sup></strike><code id='8D2ED61F49'></code></optgroup>
        1. <b id='8D2ED61F49'><label id='8D2ED61F49'><select id='8D2ED61F49'><dt id='8D2ED61F49'><span id='8D2ED61F49'></span></dt></select></label></b><u id='8D2ED61F49'></u>
          <i id='8D2ED61F49'><strike id='8D2ED61F49'><tt id='8D2ED61F49'><pre id='8D2ED61F49'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:84
          A gene-edited Yucatan minipig. -- health coverage from STAT
          A gene-edited Yucatan minipig created by eGenesis. Courtesy Liz Linder/eGenesis

          For three days in December, an ICU room at the Hospital of the University of Pennsylvania bore witness to the first-ever merging of two powerful new technologies poised to change the future of transplant medicine.

          On a gurney, a brain-dead patient lay connected to a whirring Rube Goldberg-esque machine: a tangle of tubes and siphons on wheels. From a cannula on one end, blood from the patient entered, was pumped full of oxygen and other nutrients, then pushed into a cozy, temperature-controlled chamber containing a liver — one that until very recently had belonged to a CRISPR-edited pig — before being returned to the patient.

          advertisement

          The experiment, designed to test whether a genetically engineered porcine liver kept alive in a box could support the circulatory system of a human, was a resounding success, the research team said Thursday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal
          Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

          CourtesySanofiLONDON—Inabidtoexpanditspipelineofinflammation-targetingdrugs,SanofisaidTuesdayitwasac

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          FDA sets aggressive timeline for overhauling inspection procedures

          AdobeWASHINGTON—FoodandDrugAdministrationofficialshopetofinishthisyearamassiveoverhaulofthewaytheage